Dr. Majid Tabesh is the Founder, President and CEO of Xennials Therapeutics Inc. and former President and Founder of Strategic Global Medical Affairs. He is former Oncology Global Medical Affairs Therapeutic Area Head at Astellas Pharma Inc. (2012-2014), Vice President and head of Medical Affairs at Dendreon Corp (2010-2012), Global Medical Director, Oncology at Pfizer (2008-2010) and Oncology Medical Director at Sanofi (2003-2008).
In his prior roles he was a key stakeholder and contributor in developing Life Cycle management plans which included but was not limited to development and execution of the Clinical and medical strategies as well the launch of many key products in Rheumatology and Autoimmune Disease, Urology, Oncology, Immune Oncology and Rare Disease. He was a member and later a leader of Oncology Global Medical Affairs Due Diligent teams in Sanofi, Pfizer, Dendreon and Astellas.
Dr. Tabesh completed his undergraduate at the University of Iowa with honors in Chemistry and his Medical and Graduate trainings in Pathology, Internal Medicine and Rheumatology/Immunology in Massachusetts, Ohio and Chicago, IL.
He is a member of the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), American Urological Association (AUA), American College of Rheumatology (ACR) and American Society of Investigative Pathology (ASIP).